Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- PCR (2)
- Anaplasmataceae (1)
- Biology (1)
- Bismuth subsalicylate (1)
- Camp (1)
-
- Cells (1)
- Children (1)
- Cholera (1)
- Cholera toxin (1)
- Diagnostic (1)
- Diarrhea (1)
- Diarrhoea (1)
- Dog (1)
- Donkey (1)
- Horse (1)
- IPSE (1)
- Parasites (1)
- Parasitology (1)
- Probiotic (1)
- Probiotics (1)
- Quantitative (1)
- Rat (1)
- Ruminants (1)
- Saccharomyces boulardii (1)
- Safety (1)
- Schistosomiasis (1)
- Senegal (1)
- Textbook (1)
- Ticks (1)
- Toxin (1)
- Publication
- Publication Type
Articles 31 - 31 of 31
Full-Text Articles in Tropical Medicine
Saccharomyces Boulardii And Bismuth Subsalicylate As Low-Cost Interventions To Reduce The Duration And Severity Of Cholera, Johnathan Sheele, Jessica Cartowski, Angela Dart, Arjun Poddar, Shikha Gupta, Ajay Gupta
Saccharomyces Boulardii And Bismuth Subsalicylate As Low-Cost Interventions To Reduce The Duration And Severity Of Cholera, Johnathan Sheele, Jessica Cartowski, Angela Dart, Arjun Poddar, Shikha Gupta, Ajay Gupta
Computer Science Faculty Publications
We conducted a randomised single-blinded clinical trial of 100 cholera patients in Port-au-Prince, Haiti to determine if the probiotic Saccharomyces cerevisiae var. boulardii and the anti-diarrhoeal drug bismuth subsalicylate (BS) were able to reduce the duration and severity of cholera. Subjects received either: S. boulardii 250 mg, S. boulardii 250 mg capsule plus BS 524 mg tablet, BS 524 mg, or two placebo capsules every 6 hours alongside standard treatment for cholera. The length of hospitalisation plus the number and volume of emesis, stool and urine were recorded every 6 hours until the study subject was discharged (n=83), left against …